Rising Demand for Advanced Drug Delivery Systems to Propel Pharmaceutical Packaging Market Beyond USD 299 Billion by 2035

The global pharmaceutical packaging market is on a trajectory of remarkable expansion, projected to grow from USD 128.7 billion in 2025 to USD 299.1 billion by 2035, reflecting an absolute increase of USD 169.6 billion, according to a new forecast by Future Market Insights (FMI).

This robust growth, translating to a total increase of 131.8% over the forecast period, underscores the escalating demand for advanced drug delivery systems, biologics and biosimilars adoption, and enhanced patient safety across prescription, over-the-counter, and specialty pharmaceutical products.

Rapid Growth Across Primary and Solid Dosage Packaging Segments

The pharmaceutical packaging market is predominantly driven by primary packaging, which accounts for an estimated 67.5% market share in 2025. Primary packaging remains the first line of defense in maintaining medication integrity, offering proven barrier properties, patient safety features, and compliance with regulatory standards. Pharmaceutical manufacturers continue to invest in material innovation, tamper-evident systems, and serialization technologies to enhance product differentiation while addressing patient adherence and drug stability concerns.

By drug form, solid dosage packaging holds a dominant position, representing 45.2% of the market in 2025. This segment benefits from established manufacturing patterns, strong market acceptance, and proven shelf-life performance. Advancements in moisture barrier technologies, user-friendly dosing systems, and regulatory compliance frameworks further reinforce solid dosage packaging as a key growth driver.

Global Drivers Fueling Market Expansion

Several factors are driving the pharmaceutical packaging market:

• Patient-Centric Innovations: Increasing awareness of medication adherence and patient safety is accelerating adoption of packaging solutions with superior protection and usability.
• Biologics and Specialty Pharmaceuticals: Rising adoption of temperature-sensitive biologics, injectable drugs, and specialty formulations is necessitating high-performance containment systems and cold chain management solutions.
• Regulatory Compliance and Serialization: Harmonized regulations, global serialization mandates, and anti-counterfeiting requirements are prompting pharmaceutical companies to invest in advanced packaging that ensures traceability and supply chain transparency.

Competitive Landscape: Innovation and Material Excellence at the Core

The pharmaceutical packaging market is highly competitive, featuring leading global players such as Amcor plc, Gerresheimer AG, West Pharmaceutical Services Inc., Schott AG, and AptarGroup Inc. Companies are strategically investing in barrier technologies, advanced material systems, product innovation, and smart packaging capabilities.

• Amcor plc: Focused on barrier excellence and comprehensive containment systems.
• Gerresheimer AG: Specializes in glass and plastic packaging for injectable drugs.
• West Pharmaceutical Services Inc.: Offers integrated drug delivery solutions with elastomeric positioning and operational efficiency.
• Schott AG: Provides high-performance glass packaging for parenteral applications.
• AptarGroup Inc.: Develops advanced dispensing devices and premium packaging solutions.

These insights are based on a report on Pharmaceutical Packaging Market by FMI.

Note: We would be also interested in sharing an exclusive guest article based on our research findings.

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)